SIMON H. STERTZER - 10 Jun 2022 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Role
Director
Signature
/s/ David McClung, by power of attorney
Issuer symbol
BCDA
Transactions as of
10 Jun 2022
Net transactions value
$0
Form type
4
Filing time
30 Sep 2022, 17:01:55 UTC
Previous filing
15 Jun 2021
Next filing
19 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCDA Stock Option (right to buy) Award $0 +12,434 +55% $0.000000 35,076 10 Jun 2022 Common stock 12,434 $1.44 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One hundred percent of the shares subject to the option vest and become exercisable on the one-year anniversary of the date of grant.

Remarks:

This Form 4 is being filed late due to an inadvertent administrative error.